查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198658

经桡动脉通路市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Transradial Access Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，经桡动脉通路设备市场预计将以 7.5% 的复合年增长率註册。

COVID-19 疫情影响了经桡动脉通路装置研究市场的增长，由于延迟诊断和多次预约推迟，对心臟治疗和诊断程序产生了重大影响。 此外，多项研究表明，心脏病患者特别容易感染 COVID-19，从而减少了去医院和诊断中心的次数。 例如，NCBI 于 2021 年 5 月发布的一项研究发现，在 COVID-19 流行期间，英国的心臟手术活动急剧下降，大约有 45,000 例手术出现亏损。 此外，2021 年 12 月发表在 Frontiers in Family Medicine and Primary Care 上的一项研究发现，儘管有冠状动脉疾病 (CAD) 的症状，但仍有 9.1% 的德国患者担心感染 COVID-19。他说他从未见过医生。 然而，该研究还详细说明，大多数患者在 COVID-19 流行期间接受了充分的 CAD 医疗护理。 由于心臟诊断和治疗的可用性不断提高，预计该市场将在后期受到积极影响。

由于越来越倾向于使用桡动脉通路进行介入治疗、生活方式相关疾病引起的心脏病流行以及儿科患者越来越多地使用桡动脉通路装置，因此经桡动脉通路装置市场正在扩大。

根据世卫组织 2021 年 6 月更新的数据，全球约有 3350 万人患有心房颤动 (AFib)，使其成为最常见的严重心律失常类型。我来了。 此外，英国心臟基金会于 2021 年 7 月发布的一份报告称，英国有 760 万人患有心臟和循环系统疾病。 此外，根据 2022 年 AHA 报告，全球约有 2.441 亿人患有 IHD。 到 2020 年，北非、中东、中亚、南亚和东欧将成为全球 IHD 患病率最高的地区。 随着全球人口老龄化，患有心律失常的患者数量预计会增加。 预计这将增加经桡动脉通路的采用，并推动所研究市场的增长。

根据美国心臟协会 (AHA) 于 2021 年 8 月发布的一项科学研究，外周下肢动脉疾病 (PAD) 影响着全球超过 2.3 亿人，并具有多种不利的临床结果（冠状动脉疾病），它与心脏病风险增加有关和中风，包括截肢等肢体后果。 PAD 发病率的增加将增加对需要经桡动脉入路的介入治疗的需求，从而在预测期内增加市场增长。

然而，市场增长的主要製约因素是安装和维护血管通路装置的高成本以及缺乏训练有素的专业人员，这构成了重大挑战。

经桡动脉通路市场趋势

导管部分预计在预测期内增长

导管部分预计在预测期内会出现增长。 在所有类型的动脉血管介入治疗中，通过左桡动脉的经桡动脉通路 (TRA) 是一种越来越相关的基于导管的替代方法，可替代传统的经股动脉通路。 心导管插入术是帮助诊断心脏病的常见程序。 在某些情况下，导管插入术还用于打开被球囊血管成形术或支架置入术阻塞的动脉以治疗心脏病。

心导管检查有助于诊断多种心脏病，包括动脉硬化、心肌病、先天性心脏病、心力衰竭和心臟瓣膜病。 由于全球心血管疾病负担的增加，预计导管部分将出现显着增长。 根据疾病预防控制中心 2022 年 2 月发布的更新，2020 年美国有 4.6% 的成年人被诊断出患有冠心病。 此外，截至 2021 年 2 月，美国每年约有 150 万例心脏病发作和中风。 此外，根据 2021 年泛美卫生组织的数据，心血管疾病在美洲造成 4080 万伤残调整生命年 (DALYs)。 根据国家慢性病预防与健康促进中心 2022 年 7 月更新的数据，冠心病是最常见的心脏病类型。 此外，美国每年约有 805,000 人心脏病发作。 在这种情况下，公众对疾病控制和诊断重要性的认识正在提高。

因此，上述因素有望在预测期内推动导管部分的增长。

北美在市场上占据主导地位，预计在未来几年内仍将如此

由于 CVD 患病率上升、举办的会议和研讨会数量增加以及血管通路装置研究和临床试验增加等因素，预计北美市场将以最快的速度增长。.

根据 CDC 于 2020 年 9 月发表的一篇文章，心脏病是美国的头号死因。 同一消息来源还报导说，每年约有 805,000 名美国人心脏病发作。 由于心脏病导致的死亡人数不断增加，对心脏病进行适当治疗和诊断的需求不断增加，预计经桡动脉通路装置将在预测期内显示增长，因为它们有助于诊断。

根据疾病预防控制中心 2022 年 2 月的更新，2020 年约有 2.1% 的美国儿童健康状况良好或不佳，2020 年约有 3.3% 的 5 至 11 岁儿童因任何原因缺课 11 天或更多天在过去 12 个月内生病或受伤。 此外，如上述来源所述，美国约有 20.3% 的 6 至 11 岁儿童肥胖，而肥胖是各种疾病的主要危险因素之一。预计负担会增加，推动儿童的增长正在研究的市场。

预计该地区的经桡动脉通路市场将受益于成熟的医疗保健行业和不断上涨的医疗保健成本。 例如，根据 2021 年 12 月发布的 NHEA 数据，美国将在 2020 年花费 4400 亿美元用于医疗保健。 因此，预计不断增加的医疗保健成本将刺激经桡动脉通路装置等新产品的开发，推动预测期内的市场增长。

因此，由于上述因素，北美地区有望在预测期内实现高增长率。

经桡动脉通路市场的竞争对手分析

经桡动脉通路市场竞争激烈且分散，不仅有大型企业，还有一些本地企业。 市场上的主要参与者包括 Becton、Dickinson and Company、Boston Scientific Corporation、Edward Lifesciences Corporation、Medtronic plc 和 Terumo Corporation。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 越来越倾向于使用桡动脉入路进行介入手术
    • 生活方式相关疾病导致心血管疾病患病率上升
    • 在儿科患者中增加桡动脉通路装置的使用
  • 市场製约因素
    • 血管通路装置的安装和维护成本高昂
    • 缺乏训练有素的专业人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品分类
    • 导管
    • 导丝
    • 护套和护套引入器
    • 配饰
  • 通过申请
    • 药物管理
    • 输液和营养管理
    • 输血
    • 诊断和测试
  • 最终用户
    • 医院
    • 诊所/门诊诊所
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Ameco Medical
    • Angiodynamics, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Edward Lifesciences Corporation
    • Medtronic plc
    • Merit Medical Systems
    • Nipro Medical Corporation
    • Oscor Inc
    • Smiths Medical
    • Teleflex Incorporated
    • Terumo Corporation

第7章 市场机会与今后动向

简介目录
Product Code: 60486

The transradial access devices market is expected to register a CAGR of 7.5% over the forecast period.

The COVID-19 pandemic substantially affected the treatment and diagnostic procedures for cardiac practices owing to delayed diagnosis and multiple postponed appointments, thereby impacting the growth of the studied market for transradial access devices. Furthermore, many studies suggested that people with cardiac diseases were particularly vulnerable to COVID-19, which led to a decrease in footfalls in hospitals and diagnostic centers. For instance, according to the research study published by the NCBI in May 2021, during the COVID-19 pandemic, cardiac procedural activity in England decreased dramatically, with a deficit of about 45,000 procedures. Moreover, a study published in Frontiers in Family Medicine and Primary Care in December 2021 stated that in Germany, despite having symptoms of coronary artery disease (CAD), 9.1% of patients did not see a medical practitioner due to a fear of becoming infected with COVID-19. However, the study's findings also detailed that most patients received adequate medical care during the COVID-19 pandemic for CAD. As a result of the growing availability of cardiac diagnosis and treatments, the market is expected to be favorably influenced in the latter phase, as per the analysis.

The transradial access devices market is growing due to the increasing preference for interventional procedures using radial artery access, the growing prevalence of cardiovascular diseases due to lifestyle disorders, and the increasing use of radial access devices in pediatric patients.

According to the WHO data updated in June 2021, nearly 33.5 million people globally are suffering from atrial fibrillation (AFib), which is the most common type of serious arrhythmia. Moreover, the British Heart Foundation's report published in July 2021 reported that 7.6 million people in the United Kingdom live with heart and circulatory diseases. Further, according to the 2022 AHA report, approximately 244.1 million people were living with IHD around the world. North Africa, the Middle East, Central, and South Asia, and Eastern Europe had the highest prevalence rates of IHD in the world in 2020. With the rise in the aging population worldwide, the number of patients suffering from heart rhythm disorders is likely to increase. This will lead to increased adoption of transradial access, which is expected to drive the growth of the studied market. ​

A scientific study published by the AHA in August 2021 stated that lower extremity peripheral artery disease (PAD) affects more than 230 million people worldwide and is linked to an elevated risk of several unfavorable clinical outcomes (including cardiovascular diseases like coronary heart disease and stroke and limb outcomes like amputee status). The increased incidence of PAD ultimately boosts the demand for interventional procedures requiring transradial access, augmenting the market's growth over the forecast period.

However, the major restraining factor for the market's growth is the high costs involved in the placement and maintenance of vascular access devices and the lack of trained professionals, which poses significant challenges.

Transradial Access Market Trends

Catheters Segment is Expected to Witness Growth Over the Forecast Period

The catheter segment is expected to witness growth over the forecast period. Transradial access (TRA) via the left radial artery is an alternative to traditional transfemoral access for catheter-based procedures that are becoming increasingly relevant in all types of arterial vascular interventions. Cardiac catheterization is a common procedure that can help diagnose heart disease. In some cases, catheterization is also used to treat heart disease by opening blocked arteries with balloon angioplasty and stent placement.

Cardiac catheterization helps in the diagnosis of multiple heart diseases, including atherosclerosis, cardiomyopathy, congenital heart disease, heart failure, and heart valve disease. With the growing burden of cardiovascular diseases all over the world, the catheter segment is expected to witness significant growth. As per a February 2022 published update by the CDC, in 2020, the percentage of adults diagnosed with coronary heart disease was 4.6% in the United States. In addition, as of February 2021, approximately 1.5 million heart attacks and strokes occur every year in the United States. Moreover, as per the 2021 PAHO, cardiovascular diseases account for 40.8 million disability-adjusted life years (DALYs) in the Americas. In addition, according to the National Center for Chronic Disease Prevention and Health Promotion data updated in July 2022, coronary heart disease is the most common type of heart disease. Moreover, about 805,000 people in the United States have a heart attack every year. This concerning situation is raising public awareness about disease management and the importance of diagnostics.

Thus, the abovementioned factors are expected to drive catheter segment growth over the forecast period.

North America Dominates the Market and is Expected to Follow the Same Trend for Few More Years

The North American market is likely to grow with the highest growth rate, owing to factors such as the growing prevalence of CVDs, a rising number of conferences and workshops, and an increase in research and clinical trials for vascular access devices.

According to an article published by the CDC in September 2020, heart disease is the leading cause of death in the United States. The same source also reports that every year about 805,000 Americans have a heart attack. As the number of deaths due to heart diseases is increasing, there is a continuous need for the proper treatment and diagnosis of cardiac diseases, since transradial access devices help in the diagnosis and are hence expected to show growth over the forecast period.

According to the CDC updates from February 2022, about 2.1% of children in the United States are in fair or poor health conditions in 2020, and about 3.3% of children aged 5 to 11 in 2020 missed 11 or more days of school in the last 12 months due to some form of illness or injury. Also, as per the above-mentioned source, in the United States, approximately 20.3% of children aged 6 to 11 have obesity, and as obesity is one of the major risk factors for different diseases, the burden of pediatric disease is expected to increase in the country, which would drive growth in the market studied.

The region's transradial access market is expected to benefit from the well-established healthcare industry and rising healthcare expenditure. For instance, according to NHEA data released in December 2021, the United States spent USD 440,000 million on healthcare in 2020. Thus, rising healthcare costs are expected to spur the development of new products such as transradial access devices, which are expected to drive market growth over the forecast period.

Thus, the market is expected to witness a high growth rate over the forecast period due to the factors mentioned above in the North American region.

Transradial Access Market Competitor Analysis

The transradial access market is competitive and fragmented and is inclusive of the big players along with some of the local players in the market. Some of the key players in the market include Becton, Dickinson and Company, Boston Scientific Corporation, Edward Lifesciences Corporation, Medtronic plc, and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
    • 4.2.2 Growing Prevalence of Cardiovascular Diseases Due to Lifestyle Related Diseases
    • 4.2.3 Growing Use of Radial Access Devices in Pediatric Patients
  • 4.3 Market Restraints
    • 4.3.1 High Costs Involved in the Placement and Maintenance of Vascular Access Devices
    • 4.3.2 Lack of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Catheters
    • 5.1.2 Guidewires
    • 5.1.3 Sheaths and Sheath Introducers
    • 5.1.4 Accessories
  • 5.2 By Application
    • 5.2.1 Drug Administration
    • 5.2.2 Fluid and Nutrition Administration
    • 5.2.3 Blood Transfusion
    • 5.2.4 Diagnostics and Testing
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Clinics and Ambulatory Care Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ameco Medical
    • 6.1.2 Angiodynamics, Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Edward Lifesciences Corporation
    • 6.1.6 Medtronic plc
    • 6.1.7 Merit Medical Systems
    • 6.1.8 Nipro Medical Corporation
    • 6.1.9 Oscor Inc
    • 6.1.10 Smiths Medical
    • 6.1.11 Teleflex Incorporated
    • 6.1.12 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS